ABVC BIOPHARMA, INC. quarterly report, Q3 FY2013

Filing identity and business context

The supplied metadata identifies ABVC Biopharma, Inc. and 2013 Q3, but the filing text is for Ecology Coatings, Inc. and covers the three months ended December 31, 2014, with comparative results for the three months ended December 31, 2013. Investors should verify the issuer and period before relying on this summary.

Ecology Coatings had filed for Chapter 7 bankruptcy in May 2013. The company describes a September 2014 emergence as a corporate shell following a bankruptcy asset sale and adoption of fresh-start accounting. After bankruptcy, it operated a website selling women’s apparel, having acquired Seene LLC business assets, including the MeTu trade name and website.

Financial results and position

MetricThree months ended Dec. 31, 2014Three months ended Dec. 31, 2013
Revenue$0$0
Operating expenses$1,030$10
Net loss$1,030$10
Net loss per share$(0.00)$(0.00)
Net cash from operating activities$0$(10)
Cash at period end$0$608

At December 31, 2014, reported total assets were $64,594, liabilities were $35,060, and equity was $29,534. Liabilities included accrued expenses of $19,060, a $7,000 note payable, and a $9,000 related-party note payable. The $7,000 note was due September 24, 2014, carried no interest, and was reported in default. The company reported no interest expense.

The balance sheet presentation is internally inconsistent: it lists $795 of inventory but reports total current assets of $0; reported total assets also do not reconcile with the listed asset components. The filing text does not provide a clear explanation for these discrepancies. Management nonetheless states the company had a working-capital deficit.

Changes, outlook and risks

  • Operating expenses and net loss increased by $1,020 year over year, attributed by management to administrative operations and the website. Revenue remained zero.
  • Management says new management arranged small working-capital loans to support reporting costs while a new direction is determined. The filing gives no amount, terms, or specific business outlook, and provides no financial guidance.
  • The company states that limited post-bankruptcy operations and a working-capital deficit raise substantial doubt about its ability to continue as a going concern. It needs additional capital, with no assurance financing will be available.
  • Disclosure controls were deemed ineffective because the small financial staff lacks segregation of duties. No changes in internal control were reported during the quarter.
  • The filing reports no off-balance-sheet arrangements, lease commitments, or legal proceedings. It says bankruptcy contingencies had been settled, but that statement’s timing is unclear in the text.
  • The company reported that it had not filed all required reports during the preceding 12 months. It also marked “No” for submitting and posting required interactive data files.

Important facts for investors to verify

  • Confirm that this Ecology Coatings filing, rather than an ABVC Biopharma filing, is the intended document and confirm the applicable reporting period.
  • Reconcile the balance sheet’s inventory, total current assets, and total asset figures, and clarify the stated working-capital deficit.
  • Confirm the status and terms of the defaulted $7,000 note, related-party debt, and any working-capital loans.
  • Assess the company’s going-concern risk, access to financing, and progress or viability of its post-bankruptcy apparel business.
  • Verify the delinquent-reporting and interactive-data checkboxes and whether the filing’s control weaknesses have been addressed.